AU2870899A - Oral formulation for hydrophilic drugs - Google Patents

Oral formulation for hydrophilic drugs

Info

Publication number
AU2870899A
AU2870899A AU28708/99A AU2870899A AU2870899A AU 2870899 A AU2870899 A AU 2870899A AU 28708/99 A AU28708/99 A AU 28708/99A AU 2870899 A AU2870899 A AU 2870899A AU 2870899 A AU2870899 A AU 2870899A
Authority
AU
Australia
Prior art keywords
oral formulation
hydrophilic drugs
hydrophilic
drugs
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28708/99A
Other languages
English (en)
Inventor
John F. Bauer
Walter Dziki
Mou-Ying Fu Lu
Victor E. Taylor
Zheng Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU2870899A publication Critical patent/AU2870899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU28708/99A 1998-02-26 1999-02-19 Oral formulation for hydrophilic drugs Abandoned AU2870899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3120498A 1998-02-26 1998-02-26
US09031204 1998-02-26
PCT/US1999/003675 WO1999043299A2 (fr) 1998-02-26 1999-02-19 Formulations orales pour medicaments hydrophiles

Publications (1)

Publication Number Publication Date
AU2870899A true AU2870899A (en) 1999-09-15

Family

ID=21858162

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28708/99A Abandoned AU2870899A (en) 1998-02-26 1999-02-19 Oral formulation for hydrophilic drugs

Country Status (5)

Country Link
AR (1) AR015531A1 (fr)
AU (1) AU2870899A (fr)
CO (1) CO4970788A1 (fr)
WO (1) WO1999043299A2 (fr)
ZA (1) ZA991539B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2153819B1 (fr) 2000-07-14 2012-09-05 Allergan, Inc. Utilisation d'un agent augmentant la solubilité dans une composition aqueuse comprenant tartrate de brimonidine
CN101897704B (zh) 2000-07-14 2014-10-29 阿勒根公司 含有α-2肾上腺素能激动剂的组合物
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
ES2385240B1 (es) 2010-07-26 2013-09-23 Gp-Pharm, S.A. Cápsulas de principios activos farmacéuticos y ácidos grasos poliinsaturados para el tratamiento de enfermedades de la próstata.
CN116270492A (zh) * 2023-03-30 2023-06-23 北京博恩特药业有限公司 一种注射用醋酸亮丙瑞林缓释微球及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06510046A (ja) * 1991-08-26 1994-11-10 アボツト・ラボラトリーズ 治療薬の舌下または頬投与のための組成物及び方法
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
US5853740A (en) * 1996-08-07 1998-12-29 Abbott Laboratories Delivery system for pharmaceutical agents encapsulated with oils

Also Published As

Publication number Publication date
ZA991539B (en) 1999-08-25
AR015531A1 (es) 2001-05-02
CO4970788A1 (es) 2000-11-07
WO1999043299A2 (fr) 1999-09-02
WO1999043299A3 (fr) 1999-11-04

Similar Documents

Publication Publication Date Title
AU7375598A (en) Stable oral pharmaceutical dosage forms
AU2638297A (en) Oral pharmaceutical preparation containing ibandronat
AU1267400A (en) Pharmaceutical moxifloxacin preparation
AU4143999A (en) Oral composition comprising capsules
AU1827799A (en) Oral delivery formulation
AU4328800A (en) Pharmaceutical formulation
AU6715600A (en) Pharmaceutical formulations
AU5838398A (en) Rapamycin formulations for oral administration
AU2564399A (en) Isoflavanoid formulations for oral administration
IL132986A0 (en) Rapamycin formulation for oral administration
AU7735798A (en) Pharmaceutical composition for oral administration
AU4977300A (en) Pharmaceutical formulations
AU1732401A (en) Medicinal compositions for oral use
AU1385801A (en) Pharmaceutical formulations
AU2870899A (en) Oral formulation for hydrophilic drugs
AU5347996A (en) Preparation for oral administration
AU5378599A (en) Oral formulation
AU1688099A (en) Pharmaceutical preparation
AU5415699A (en) Water-soluble pharmaceutical formulation for administering sildenafil
AU3839900A (en) Pharmaceutical formulation
AU6092698A (en) Combination preparation for orally administered antibiotics
AU6473699A (en) Aqueous drug formulation for oral application
AU3860797A (en) Pharmaceutical formulations for oral administration
AU1304601A (en) Solid preparations for oral use
AU5182099A (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase